Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Pressure Wound Therapy System



Status:Completed
Conditions:Gastrointestinal, Podiatry, Diabetes
Therapuetic Areas:Endocrinology, Gastroenterology, Orthopedics / Podiatry
Healthy:No
Age Range:18 - Any
Updated:4/2/2016
Start Date:June 2012
End Date:December 2015
Contact:Peter Schubart, MD, PhD
Email:schubart@ix.netcom.com

Use our guide to learn which trials are right for you!

Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Negative Pressure Wound Therapy System for Treatment of Non-responding Venous Stasis and Diabetic Lower Extremity Ulcers

The primary purpose of this study is to evaluate the safety and efficacy of the concurrent
use of Apligraf® and the SNaP® Wound Care System for the treatment of diabetic and venous
stasis lower extremity ulcers.


Inclusion Criteria:

- Wound < 10 cm in greatest diameter

- Wound age > 4 weeks and patient shows < 50% wound area healing after 4 weeks of
treatment

- Patient > 18 years of age

- Patient is willing and able to sign consent

- Patient is willing and able to complete study visits and comply with study dressing
protocols

Exclusion Criteria:

- Wound size reduction of > 50% in last 4 weeks of treatment

- Patients with active wound infections, including cellulitis and osteomyelitis

- Patients with wounds not able to have eschar debrided

- ABI < 0.65 or SPP < 30mmHg

- Patients with wounds in anatomic areas which preclude achieving an airtight seal for
NPWT

- Ulcers due to inflammatory conditions such as rheumatoid arthritis, lupus,
scleroderma, vasculitis, calciphylaxis, etc.

- Patients with allergy to or intolerance of any of the wound dressing materials
expected to be used during the trial.

- Pregnant patients

- Patients unable to tolerate NPWT

- Patients with dialysis dependent ESRD

- Index ulcer is on the plantar surface of the foot
We found this trial at
1
site
San Jose, California 95128
?
mi
from
San Jose, CA
Click here to add this to my saved trials